| Name | fr901464 |
|---|---|
| Synonyms |
WB 2663B
[(E,2S)-5-[[(2R,5S,6S)-6-[(2E,4E)-5-[(4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate [(E,2S)-5-[[(2R,5S,6S)-6-[(2E,4E)-5-[(5S,7R,8R)-5,8-dihydroxy-5-methyl-2,6-dioxaspiro[2.5]octan-7-yl]-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate |
| Description | FR901464 is a potent spliceosome inhibitor with prominent anti-tumor and anti-cancer effects[1]. |
|---|---|
| Related Catalog | |
| In Vitro | FR901464 (10-20 ng/ml; 6-24 hours) inhibits the growth of murine solid tumors, Colon 38 carcinoma and Meth A fibrosarcoma. FR901464 induces characteristic G1 and G2/M phase arrest in the cell cycle and internucleosomal degradation of genomic DNA with the same kinetics as activation of SV40 promoter-dependent cellular transcription in M-8 tumor cells[1]. FR901464 (1-10 ng/ml; 16 hours) suppresses the transcription of some inducible endogenous genes but not house keeping genes in M-8 cells[1]. FR901464 exhibits potent anticancer activity. It shows enhancement of activity of a promoter of the SV40 DNA tumor virus at 10 nM concentration in M-8 cells[1]. |
| References |
| Density | 1.21g/cm3 |
|---|---|
| Boiling Point | 702.7ºC at 760mmHg |
| Molecular Formula | C27H41NO8 |
| Molecular Weight | 507.61600 |
| Flash Point | 378.8ºC |
| Exact Mass | 507.28300 |
| PSA | 130.34000 |
| LogP | 3.15270 |
| Vapour Pressure | 7.94E-23mmHg at 25°C |
| Index of Refraction | 1.553 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xi |
|---|
| Precursor 5 | |
|---|---|
| DownStream 0 | |